What’s going on for the future of R&D programmes
by Giuliana Miglierini After the European elections of June 2024, a vivid debate arose between the R&I stakeholders…
The new European Supply Chain Law and a Transatlantic partnership
September 6, 2024 by Giuliana Miglierini The new EU Corporate Sustainability Due Diligence Directive (EU) 2024/1760 (CSDDD), also…
The EU Parliament voted its position on the Unitary SPC
by Giuliana Miglierini The intersecting pathways of revision of the pharmaceutical and intellectual property legislations recently marked the…
PGEU annual medicine shortages report
by Giuliana Miglierini The situation of medicine shortages is getting worse, with many countries which in 2023 experienced…
Approvals and flops in drug development in 2023
by Giuliana Miglierini Approvals and flops in drug development in 2023 The European Medicines Agency published its annual…
European Council’s recommendations on R&I
by Giuliana Miglierini The end of 2023 saw some steps forward to better support the European framework on…